MedTrace Logo

Safety and Efficacy of Chronic Hypnotic Use

NCT01006525 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 116

Last updated 2011-11-07

No results posted yet for this study

Summary

The purpose of the study is to determine how safe and effective it is for people with insomnia to use zolpidem on a nightly basis for one year.

Conditions

  • Primary Insomnia

Interventions

DRUG

zolpidem

placebo or zolpidem (10mg)daily for one year

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Timothy A. Roehrs, Ph.D. · Henry Ford Health System

  • Surilla Randall, Ph.D. · Henry Ford Health System

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01006525 on ClinicalTrials.gov